Session Details

[27P-pm]Virology

Thu. Mar 27, 2025 1:30 PM - 5:00 PM JST
Thu. Mar 27, 2025 4:30 AM - 8:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])

[27P-pm280S]Anti-influenza and anti-SARS-CoV-2 activities of prohibitin ligand X

○Itsuki Tomita1, Masaki Shoji1, Hinako Sato1, Rina Hashimoto2, Laurent Désaubry3, Kazuo Takayama2, Takashi Kuzuhara1 (1. Lab. of Biochem., Facul. of Pharm. Sci., Tokushima Bunri Univ. , 2. Center for iPS Cell Res. and Appl. (CiRA), Kyoto Univ., 3. Lab. of Regen. Nanomed. (UMR 1260) INSERM, Univ. of Strasbourg.)

[27P-pm281]Analysis of broad antiviral effects of novel small molecule compounds with membrane fusion inhibitory activity

○Hirotaka Sato1, Michiaki Masuda1, Ryosuke Muroyama1 (1. Sch. Med., Dokkyo Med. Univ.)

[27P-pm282S]Development of the anti HSV-1 compound

○Ayumi Sugita1, Takahiro Matsumoto1, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical Univ.)

[27P-pm283S]Characterization of Vero cells persistently infected with Japanese Encephalitis Virus

○Natsuko Koike1,2, Non Miyata2, Tomoharu Mizukami2, Kohji Noguchi1,2, Masayoshi Fukasawa1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Sci., 2. Dept Biochemistry and Cell Biology, NIID)

[27P-pm284]Identification of inhibitors for viral proteases using cell-based protease assay

○Kentaro Uemura1,2,3, Junki Hirano1,2,3, Kazuma Okada1,2, Chikako Ono1,2,3, Shuhei Taguwa1,2,3, Yoshiharu Matsuura1,2,3 (1. Center for Infectious Disease Education and Research, Osaka University, 2. Research Institute for Microbial Diseases, Osaka University, 3. Center for Advanced Modalities and DDS, Osaka University)

[27P-pm285S]Impact of the inhibition of LGALS3 on the life cycle of Herpes Simplex Virus Type 1

○Mao Nishikawa1, Hikaru Shigenaka1, Ayano Kawahara1, Azuki Yasuoka1, Yuika Metsugi1, Kazuki Kaneko1, Mayuko Yagi1, Atsushi Jun Komano1 (1. Osaka Medical and Pharmaceutical University)

[27P-pm286S]Search for bispecific antibodies targeting the SARS-CoV-2 spike protein S2 region

○Kaoru Sato1, Yuichiro Yamamoto1, Yuko Nakamura2, Yoshimi Shimizu2,3, Motohiko Ogawa4, Masayoshi Fukasawa2, Mika Kaneko5, Yukinari Kato5, Kohji Noguchi1 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. of Sci., 2. Dept. Biochem. Cell Biol., NIID., 3. Sch. Med., Showa Univ., 4. Dept. Virol I., NIID., 5. Grad. Sch. Med., Tohoku Univ.)

[27P-pm287]Establishment of a novel detection method for human papillomavirus DNA integration related to cervical and oropharyngeal carcinogenesis

○Kento Fukano1,2, Kousho Wakae2, Nao Naganori3, Masumichi Saito2, Takeo Matsumoto4, Takashi Iizuka4, Hiroshi Fujiwara4, Satoru Kondo4, Haruka Kudo2, Takae Toyoshima2, Azusa Kamikawa1, Takahiro Matsudaira5, Hideki Aizaki2, Moto Kimura1, Masanori Isogawa2, Wataru Sugiura1, Masamichi Muramatsu2,6 (1. NCGM, 2. NIID, 3. Hokkaido University, 4. Kanazawa University, 5. FASMAC, 6. FBRI)

[27P-pm288S]Neurocytotoxic activity of protein aggregates produced by HSV-1 infection

○Yasuhiro Ikeda1, Moe Kurohasi1, Tatsuo Yamaguchi1, Yuki Iwaisako1, Kei Suga3, Kazuhiro Nakaso2, Masahiro Fujimuro1 (1. kyoto Pharmaceutical Univ., 2. Faculty of Medicine Tottori Univ., 3. Faclty of Medicine Kyorin Univ.)

[27P-pm289S]Identification and analysis of new gene possessed by guinea pig cytomegalovirus.

○Yukiya Okada1, Hiroki Kondo1, Juri Koizumi1, Keita Takahashi1, Tetsuo Koshizuka1 (1. Gifu Pharmaceutical Univesity)